Literature DB >> 36268234

Hepatocellular carcinoma with portal invasion, still a place for liver surgery in the era of immunotherapy?

Héloïse Giudicelli1, Claire Goumard2, Manon Allaire1.   

Abstract

Entities:  

Year:  2022        PMID： 36268234      PMCID： PMC9577992          DOI： 10.21037/hbsn-22-373

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   8.265


× No keyword cloud information.
  7 in total

1.  Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma.

Authors:  Ann-Lii Cheng; Shukui Qin; Masafumi Ikeda; Peter R Galle; Michel Ducreux; Tae-You Kim; Ho Yeong Lim; Masatoshi Kudo; Valeriy Breder; Philippe Merle; Ahmed O Kaseb; Daneng Li; Wendy Verret; Ning Ma; Alan Nicholas; Yifan Wang; Lindong Li; Andrew X Zhu; Richard S Finn
Journal:  J Hepatol       Date:  2021-12-11       Impact factor: 25.083

2.  A new staging system for hepatocellular carcinoma associated with portal vein tumor thrombus.

Authors:  Wan Yee Lau; Kang Wang; Xiu-Ping Zhang; Le-Qun Li; Tian-Fu Wen; Min-Shan Chen; Wei-Dong Jia; Li Xu; Jie Shi; Wei-Xing Guo; Ju-Xian Sun; Zhen-Hua Chen; Lei Guo; Xu-Biao Wei; Chong-De Lu; Jie Xue; Li-Ping Zhou; Ya-Xing Zheng; Meng Wang; Meng-Chao Wu; Shu-Qun Cheng
Journal:  Hepatobiliary Surg Nutr       Date:  2021-12       Impact factor: 8.265

3.  Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion.

Authors:  Takashi Kokudo; Kiyoshi Hasegawa; Yutaka Matsuyama; Tadatoshi Takayama; Namiki Izumi; Masumi Kadoya; Masatoshi Kudo; Yonson Ku; Michiie Sakamoto; Osamu Nakashima; Shuichi Kaneko; Norihiro Kokudo
Journal:  J Hepatol       Date:  2016-06-04       Impact factor: 25.083

4.  Systematic review of the outcomes of surgical resection for intermediate and advanced Barcelona Clinic Liver Cancer stage hepatocellular carcinoma: A critical appraisal of the evidence.

Authors:  Ye Xin Koh; Hwee Leong Tan; Weng Kit Lye; Juinn Huar Kam; Adrian Kah Heng Chiow; Siong San Tan; Su Pin Choo; Alexander Yaw Fui Chung; Brian Kim Poh Goh
Journal:  World J Hepatol       Date:  2018-06-27

5.  Neoadjuvant Three-Dimensional Conformal Radiotherapy for Resectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Randomized, Open-Label, Multicenter Controlled Study.

Authors:  Xubiao Wei; Yabo Jiang; Xiuping Zhang; Shuang Feng; Bin Zhou; Xiaofei Ye; Hui Xing; Ying Xu; Jie Shi; Weixing Guo; Dong Zhou; Hui Zhang; Huichuan Sun; Cheng Huang; Congde Lu; Yaxin Zheng; Yan Meng; Bin Huang; Wenming Cong; Wan Yee Lau; Shuqun Cheng
Journal:  J Clin Oncol       Date:  2019-07-08       Impact factor: 44.544

Review 6.  Comparison of the current international guidelines on the management of HCC.

Authors:  Friedrich Foerster; Peter Robert Galle
Journal:  JHEP Rep       Date:  2019-05-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.